http://orcid.org/0000-0003-0244-6607
References
- Bhutada NS, Cook CL, Perri III M. Consumers responses to coupons in direct-to-consumer advertising of prescription drugs. Health Mark Q. 2009;26:333–346. doi: 10.1080/07359680903315902
- Palmer JA, Timm AR, Neumann PJ. Drug company advertising in medical journals about the health-economic advantages of their products for 2000–2006 versus 1990–1999. J Manag Care Pharm. 2008;14:749–755.
- Woloshin S, Schwartz LM, Tremmel J, et al. Direct-to-consumer advertisements for prescription drugs: what are Americans being sold? Lancet. 2001;358:1141–1146. doi: 10.1016/S0140-6736(01)06254-7
- Weppner WG, Hollon MF, Chew LD, et al. Direct-to-consumer offers for free and discounted medications on the internet: a content analysis of “e-samples”. Arch Intern Med. 2009;169:2024–2030. doi: 10.1001/archinternmed.2009.397
- Johar K. An insider’s perspective: defense of the pharmaceutical industry’s marketing practices. Albany Law Rev. 2012;76:299–334.
- Glasgow C, Schommer JC, Gupta K, et al. Promotion of prescription drugs to consumers: case study results. J Manag Care Pharm. 2002;8:512–518.
- Friedman M, Gould J. Physicians’ attitudes toward direct-to-consumer prescription drug marketing. J Med Market. 2007;7:33–44. doi: 10.1057/palgrave.jmm.5050063
- Becker SJ, Midoun MM. Effects of direct-to-consumer advertising on patient prescription requests and physician prescribing: a systematic review of psychiatry-relevant studies. J Clin Psychiatry. 2016;77:e1293–e1300. doi: 10.4088/JCP.15r10325
- Allan GM, Lexchin J, Wiebe N. Physician awareness of drug cost: a systematic review. PLoS Med. 2007;4:e283. doi: 10.1371/journal.pmed.0040283
- Korn LM, Reichert S, Simon T, et al. Improving physicians’ knowledge of the costs of common medications and willingness to consider costs when prescribing. J Gen Intern Med. 2003;18:31–37. doi: 10.1046/j.1525-1497.2003.20115.x
- Reichert S, Simon T, Halm EA. Physicians’ attitudes about prescribing and knowledge of the costs of common medications. Arch Intern Med. 2000;160:2799–2803. doi: 10.1001/archinte.160.18.2799
- Czechowski JL, Tjia J, Triller DM. Deeply discounted medications: implications of generic prescription drug wars. J Am Pharm Assoc. 2010;50:752–757. doi: 10.1331/JAPhA.2010.09114
- Cogdill B, Nappi JM. Assessment of prescribers’ knowledge of the cost of medications. Ann Pharmacother. 2012;46:200–207. doi: 10.1345/aph.1Q485
- Gilhooley M. Heal the damage: prescription drug consumer advertisements and relative choices. J Health Law. 2005;38:1–44.
- Hayes AF, Krippendorff K. Answering the call for a standard reliability measure for coding data. Commun Methods Meas. 2007;1:77–89. doi: 10.1080/19312450709336664
- Baron RJ. What’s keeping us so busy in primary care? A snapshot from one practice. N Engl J Med. 2010;362:1632–1636. doi: 10.1056/NEJMon0910793
- Riggs KR, DeCamp M. Providing price displays for physicians: which price is right? JAMA. 2014;312:1631–1632. doi: 10.1001/jama.2014.7105